Orexin receptor antagonists: a review of promising compounds patented since 2006

By Coleman Paul J   Renger John J  

Expert Opinion on Therapeutic Patents, Vol. 20, Iss. 3, 2010-03 ,pp. : 307-324

Informa Healthcare

Access to resources Recommend Favorite

Cataleptic effects of γ-hydroxybutyrate (GHB) and baclofen in mice: mediation by GABA_B receptors, but differential enhancement by N-methyl-d-aspartate (NMDA) receptor antagonists

By Koek Wouter   France Charles  

Psychopharmacology, Vol. 199, Iss. 2, 2008-08 ,pp. : 191-198

Springer Publishing Company

Access to resources Recommend Favorite

N-Methyl-D-Aspartate Receptor (NMDA) Antagonists as Potential Pain Therapeutics

By  

Current Topics in Medicinal Chemistry, Vol. 6, Iss. 8, 2006-04 ,pp. : 749-770

Bentham Science Publishers

Access to resources Recommend Favorite

Novel CCR5 antagonists for the treatment of HIV infection: a review of compounds patented in 2006 – 2008

By Yang Hanbiao   Rotstein David M  

Expert Opinion on Therapeutic Patents, Vol. 20, Iss. 3, 2010-03 ,pp. : 325-354

Informa Healthcare

Access to resources Recommend Favorite

Selective Upregulation of Brain-derived Neurotrophic Factor (BDNF) Transcripts and BDNF Direct Induction of Activity Independent N-Methyl-D-aspartate Currents in Temporal Lobe Epilepsy Patients with Hippocampal Sclerosis

By Wang FJ   Li CM   Hou XH   Wang XR   Zhang LM  

The Journal of International Medical Research, Vol. 39, Iss. 4, 2011-07 ,pp. : 1358-1368

Field House Publishing

Access to resources Recommend Favorite